She felt bloated for months and blamed stress and diet. Once the swelling would not fade, she pushed for tests and learned she had colon cancer at 37. A few weeks after surgery, genetic testing revealed a BRCA2 mutation, a finding that reshaped her care and her family’s future.
How a common symptom led to an unexpected cancer diagnosis
What began as intermittent bloating turned into a series of appointments. Her primary care doctor first suggested lifestyle changes. When symptoms persisted, a gastroenterologist ordered a colonoscopy. That exam found a tumor in the sigmoid colon. Biopsy confirmed adenocarcinoma, the most common form of colorectal cancer.
She had none of the classic risk flags. She did not smoke and had no inflammatory bowel disease. Her emergency was the rising tide of young-onset colorectal cancer, a trend seen globally. Being in her 30s did not protect her, and the diagnosis came as a shock.
Treatment path: surgery, chemo, and tough choices
Facing a diagnosis at 37 meant balancing cancer care with life plans. Her treatment team proposed a multi-step plan:
- Surgical resection to remove the tumor and affected lymph nodes.
- Pathology and staging to guide additional therapy.
- Adjuvant chemotherapy to reduce recurrence risk.
- Supportive care for fertility, nutrition, and mental health.
Her operation was successful and staging suggested adjuvant chemotherapy. The medical team discussed fertility preservation before starting chemo. She chose to freeze eggs, a choice many young patients consider before cytotoxic treatment.
Surprise finding: BRCA2 mutation alters the story
Genetic testing after her diagnosis revealed a BRCA2 pathogenic variant. BRCA1 and BRCA2 are better known for their link to breast and ovarian cancer. Finding BRCA2 in a colon cancer patient is less common. Still, the result mattered immediately.
The mutation changed surveillance and family counseling. Her oncologist explained that BRCA2 carriers face elevated risks for certain cancers. Some evidence also suggests a modest rise in colorectal risk in BRCA2 carriers, though research is still evolving. For her, the BRCA2 result meant more than the colon tumor. It opened a new conversation about prevention and screening for relatives.
What a BRCA2 result means for treatment decisions
A BRCA2 mutation can influence therapy choices. Certain DNA-damage targeting drugs, like PARP inhibitors, are effective in BRCA-mutated cancers such as ovarian and breast. Their role in colon cancer is investigational but growing.
Her care team considered:
- Standard chemotherapy for colorectal cancer.
- Clinical trials testing targeted agents in BRCA-mutant tumors.
- Increased surveillance for other BRCA-associated cancers.
They also discussed preventive options for organs at risk. Surgical removal of breasts or ovaries is common for women with BRCA mutations. While not directly tied to colon cancer, these options may be considered to lower future cancer risk.
Family impact: cascade testing and risk reduction
Genetic results prompted a cascade of conversations with family members. BRCA2 is inherited in an autosomal dominant pattern. Each first-degree relative has a 50% chance of carrying the same mutation.
She and her siblings made a plan:
- Notify immediate relatives so they can get genetic counseling.
- Offer targeted testing to at-risk family members.
- Start personalized screening if they are carriers.
Genetic counselors helped them navigate options. Some relatives decided on testing immediately. Others chose to wait. The family began updating their medical surveillance plans and discussing reproductive options like preimplantation genetic testing.
Screening lessons: when to test and what to watch for
Her story highlights gaps in awareness and screening. Current colorectal screening guidelines vary by country. In many places, routine screening starts at age 45. For people with significant family history or inherited syndromes, screening may begin much earlier.
Key signs that justify early evaluation:
- Persistent bloating or abdominal pain.
- Changes in bowel habits lasting weeks.
- Rectal bleeding or unexplained anemia.
- Family history of colorectal or hereditary cancer syndromes.
Genetic testing has become more accessible. When cancer appears at a young age, clinicians increasingly recommend a multi-gene panel. That panel often includes BRCA1/2, Lynch syndrome genes, and others linked to hereditary cancer.
Navigating uncertainty: what the science says about BRCA2 and colorectal risk
The relationship between BRCA2 and colorectal cancer is not definitively settled. Some studies show a small increase in colorectal risk among BRCA2 carriers. Others find no clear link. Experts urge caution and recommend individualized care.
For patients and families, this means:
- Follow evidence-based screening for BRCA-associated cancers.
- Discuss colorectal surveillance if personal or family history suggests risk.
- Consider enrolling in research studies to help clarify risk.
Her oncologist explained that science evolves. Until stronger data exist, decisions will be personalized and made in consultation with specialists.
Emotional and practical fallout: coping after a double surprise
A cancer diagnosis alone is disruptive. Add a hereditary mutation, and everything feels more urgent. She described a complex mix of fear, relief, and empowerment. Relief came from having answers. Fear came from the thought of relatives who might also be at risk.
Support came from multiple sources:
- Genetic counselors and patient navigators.
- Support groups for young-onset colorectal cancer.
- Mental health services specializing in cancer and hereditary risk.
She also found practical help through social workers who connected her with fertility services, financial counseling, and community resources.
Practical next steps for people worried about symptoms or family history
If you or a loved one has persistent gastrointestinal symptoms or a strong family history, act early. Steps to consider:
- Document symptoms and timelines before appointments.
- Ask your doctor about early colonoscopy if you have risk factors.
- Request genetic counseling when cancer occurs at a young age.
- Share genetic results with family and encourage testing when indicated.
Early detection saves lives. Awareness and timely action can change outcomes for individuals and their families.
Similar Posts:
- Olivia Munn’s Genetic Battle: How Her Mom’s Breast Cancer Raises Awareness
- Colorectal cancer surge: now deadliest cancer for people under 50
- Katherine LaNasa reveals early breast cancer detection saved her life
- Colon cancer at 32: doctors dismissed her as too young
- James Van Der Beek on colorectal cancer: it’s harder than he expected
Cole is a passionate vegan dessert artist with a knack for turning indulgent classics into plant-based masterpieces. His sweet creations are where flavor meets conscious living.